Aktis Oncology, Inc. Common stock (AKTS) — Cash Flow-to-Debt Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2024, meaning its operating cash flow of $-12.80 Million could theoretically repay 0% of its total liabilities ($413.98 Million) in one year. See Aktis Oncology, Inc. Common stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aktis Oncology, Inc. Common stock Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Aktis Oncology, Inc. Common stock across 21 annual periods. Also explore AKTS net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aktis Oncology, Inc. Common stock (2014–2024)
Year-by-year debt coverage analysis for Aktis Oncology, Inc. Common stock. For market capitalisation and broader financial context, see how much is Aktis Oncology, Inc. Common stock worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | $14.76 Million | $413.98 Million | ▲ +111.2% |
| 2024 | -0.32x | $-40.35 Million | $126.83 Million | ▼ -78.8% |
| 2023 | -0.18x | $-30.00 Million | $168.66 Million | ▲ +75.1% |
| 2023 | -0.72x | $-44.82 Million | $62.68 Million | ▼ -521.6% |
| 2022 | -0.12x | $-18.12 Million | $157.55 Million | ▲ +85.3% |
| 2022 | -0.78x | $-45.20 Million | $57.91 Million | ▲ +0.0% |
| 2021 | -0.78x | $-45.20 Million | $57.91 Million | ▲ +79.8% |
| 2021 | -3.87x | $-29.36 Million | $7.58 Million | ▼ -444.1% |
| 2020 | -0.71x | $-21.30 Million | $29.94 Million | ▲ +0.0% |
| 2020 | -0.71x | $-21.30 Million | $29.94 Million | ▲ +11.4% |
| 2019 | -0.80x | $-17.67 Million | $21.99 Million | ▲ +0.0% |
| 2019 | -0.80x | $-17.67 Million | $21.99 Million | ▲ +12.6% |
| 2018 | -0.92x | $-14.20 Million | $15.46 Million | ▲ +0.0% |
| 2018 | -0.92x | $-14.20 Million | $15.46 Million | ▲ +49.0% |
| 2017 | -1.80x | $-5.55 Million | $3.08 Million | ▲ +0.0% |
| 2017 | -1.80x | $-5.55 Million | $3.08 Million | ▼ -205.4% |
| 2016 | -0.59x | $-1.10 Million | $1.87 Million | ▲ +0.0% |
| 2015 | -0.59x | $-1.10 Million | $1.87 Million | ▲ +80.3% |
| 2015 | -2.99x | $-980.04K | $327.66K | ▲ +0.0% |
| 2014 | -2.99x | $-980.04K | $327.66K | ▲ +96.6% |
| 2014 | -88.17x | $-26.98K | $306.00 | — |